Our People

Professor Barry J. Marshall

Professor Marshall is a world authority on H.pylori. He is the co-discoverer that H.pylori plays a major causative role in peptic ulcer diseases and co-recipient of the 2005 Nobel Prize for Physiology or Medicine as well as numerous other prestigious awards (including the 1995 Lasker Award). Professor Marshall was elected as a Fellow of the Royal Society in 1999 and the US National Academy of Sciences in 2008.

He is one of the most esteemed and pre-eminent biomedical scientists in the world today. His discovery has revolutionised the management of peptic ulcer disease, resulting in a cure for peptic ulcers. Related research into a diagnostic test for H.pylori led to a patentable technology and the formation of TriMed Distributors Pty Ltd, a successful private company. Dr Marshall is the founder of Ondek®. He is also a Clinical Professor at the University of Western Australia and a practising specialist gastroenterologist.

Aiden Blechynden

Prior to joining Tri-Med in July 2019, Aiden had an extensive career spanning over twenty years in commercially focused roles in marketing and strategy. Aiden spent over a decade working at Australia’s largest cooperative, the CBH Group in roles including Funds Management and Corporate Strategy. After this, he spent a further three years as Commercial Manager at Plumgrove overseeing the Eastern States Storage and Handling division.

Aiden graduated with a Bachelor of Commerce from Curtin University in 1999.

As General Manager of Tri-Med, Aiden is responsible for the overall management of the business as well as the development and execution of strategy. Aiden is heavily invested in, and is proud of Tri-Med’s history, having had a long association with Professor Marshall. Aiden is passionate about the product suite and maintaining its positioning in the market as the original and best ulcer diagnostic. Aiden also has a keen focus on growing market share through maintaining and building strong relationships through the distribution network.

Joel Blechynden

Joel joined Tri-Med as Operations Manager/Director in November 2019. Prior to this Joel was a founding director of a successful surveying company where he managed a diverse range of construction projects throughout Western Australia. As Operations Manager, Joel is responsible for all operational aspects of the business globally, including all warehouse, storage and logistical functions. Joel is passionate about finding the path of least cost to supply for our customer base. Joel has a keen interest in business process improvement and executing along the supply chain to maintain an exceptional level of service for our customers.

Clare Newby

Clare has over two decades of invaluable experience in the pharmaceutical and analytical chemistry sectors. Joining Tri-Med in May 2023, she brings with her expertise in pharmaceutical formulation, quality assurance, and regulatory compliance across international markets.

Her career began as an analytical chemist for a pharmaceutical manufacturing company. During this time, Clare attended day-release studies, culminating in the completion of a BSc degree with Honors in Chemistry and Analytical Chemistry.

Throughout her career, Clare has exhibited a wide-ranging proficiency in multiple pharmaceutical formats, encompassing solid and liquid doses, dry powder inhalers, topical creams, and oral spray delivery technologies. Her expertise extends beyond formulation and testing, encompassing the process from product initiation to commercialization. 

Clare has experience liaising with third-party contract manufacturers, navigating the intricacies of product registration across multiple countries, and maintaining strict adherence to the regulatory standards set forth by agencies such as ISO, TGA, MHRA, and ANVISA.

At Tri-Med, Clare undertakes the responsibility of overseeing regulatory compliance, managing the quality management system, and ensuring the high standards of product components for a global market. Her leadership, managerial expertise, and adeptness in research and development activities, offer an invaluable depth of expertise in operating within the frameworks of diverse regulatory agencies.

Bhanu Rahoni

Throughout a career span of over twenty years, Bhanu has gained extensive experience in marketing, business development, and sales in various organisations, including biotechnology, pharmaceutical, medical devices companies, as well as the Australian and Canadian governments. In his early career, Bhanu worked for biotech and pharmaceutical companies, where he focused on product marketing, developing and executing marketing strategies to promote and launch new products.

After several years in the private sector, Bhanu transitioned to the Canadian Government, where he helped launch the first office for the British Columbia Trade and Investment Organisation in India and worked as a policy advisor. Post his Canadian government stint, Bhanu joined the Government of Western Australia where he was responsible for identifying new business opportunities, building relationships with potential customers, and promoting investments into Western Australia.

Bhanu holds a Bachelor of Bio-Science and a Masters of Business Administration majoring in Marketing and Human Resources.

In his role as Country Head - EMEA, Bhanu is responsible for developing new markets for Tri-Med's core products, servicing existing markets and managing distributor relationships.